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Context: Docosahexaenoic acid (DHA) is an important fatty acid required for neurological devel-
opment but its importance during early fetal neurological organogenesis is unknown.
Objective: To assess plasma fatty acid changes in early pregnancy in women undergoing natural
cycle-frozen embryo transfer as a means of achieving accurately-timed periconceptual sampling.
Design:Women undergoing frozen embryo transfer were recruited and serial fasting blood sam-
ples were taken pre-luteinising hormone (LH) surge, and at days 18, 29 and 45 post-LH surge and
fatty acids were analysed using gas chromatography.
Setting: Assisted Conception Unit, Glasgow Royal Infirmary, Scotland
Main outcomemeasures: Plasma fatty acid concentrations, influence of twin pregnancies on DHA
plasma concentration.
Results: In pregnant women, there was a rapid, early increase in the maternal rate of change of
plasmaDHA concentration observed by 29 days post-LH surge (meanSD, from0.11.3 to 1.62.9
nmol DHA per mL plasma per day). This early pressure to increase plasma DHA concentration was
further emphasised in twin pregnancieswhere the increase inDHA concentrationover 45 dayswas
two-fold higher than in singleton pregnancies (meanSD increase, 7439 nmol/mL versus 3640
nmol/mL). An index of delta-6 desaturase activity increased 30%andpositively correlatedwith the
rate of change of DHA concentration between day 18 and 29-post LH surge (R-squared adjusted
41%, P0.0002). DHA was the only fatty acid with a continual accelerated increase in plasma
concentration and a positive incremental area under the curve (meanSD, 632911 nmol/mL x
day) over the first 45 days of gestation.
Conclusions: An increase in maternal plasma DHA concentration is initiated in human pregnancy
prior to neural tube closure which occurs at 28 days’ gestation.
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The long chain polyunsaturated fatty acids (LC PUFA),docosahexaenoic acid (DHA) and arachidonic acid
(AA), are important in neurological development as these
lipids arekeymembrane componentsofnervous tissues (1,
2). The fetal-placental circulation is established around
9–13 weeks of gestation, after which the growing fetus
preferentially acquires DHA and AA from maternal
plasma via placental transport (3, 4). In contrast, the es-
sential dietary fatty acids linoleic acid (LA) and-linolenic
acid (ALA), which are the precursors of LC PUFA, are at
best minimally transferred to the fetus from maternal
plasma (3, 5). We have previously shown that maternal
erythrocyte DHA concentrations (an indicator of the pre-
vious 3 months’ change in concentration) increased 17%
by the end of the first trimester and continued to signifi-
cantly increase throughout pregnancy to 26%above post-
partum (nonpregnant) concentrations by the third trimes-
ter (6). AA concentrations did not change but the
concentration of nervonic acid important in myelination,
increased by 5% and 22%by the end of the first and third
trimester respectively (6). Thus plasma concentrations of
fatty acids essential for brain development are increased
by the end of the first trimester and are available for pla-
cental transport to the fetus.
The sources of LC PUFA for this increase in plasma
concentration or “mobilization” in pregnantwomen have
not been fully identified and could include ingestion in
maternal diet, maternal synthesis from shorter chain pre-
cursors or release from maternal membrane stores and
adipose tissue. Our previous study suggested that ALA,
but not LA, is mobilized for LC PUFA synthesis in preg-
nancy (6). Humans possess the necessary enzymes to me-
tabolize these two precursor fatty acids to LC PUFA (Sup-
plemental Figure 1). Healthy, nonpregnant individuals
can convert LA to AA by desaturation (-6 desaturase
/FADS2), elongation (ELOVL5) and further desaturation
(-5 desaturase/FADS1) in the liver (7). These same en-
zymes, in parallel, also convert ALA to eicosapentaenoic
acid (EPA) and ultimately DHA but these conversions,
particularly to DHA, are limited. Interestingly this path-
way is more efficient in women than in men suggesting
gender-specific roles for this pathway (8). The dominance
of the omega-6 LCPUFApathway can be explained by the
competition of LA and ALA for the same -6 desaturase
enzyme, given that dietary LA intake is 8 fold higher than
that of ALA (9).
The critical requirement of DHA for fetal brain devel-
opment, and the poor efficiency of its synthesis in humans,
is therefore a metabolic problem to be overcome in preg-
nancy. Furthermore, as the first primitive brain cells are
formed by day 15 of gestation, neural tube closure occurs
by 28 days’ gestation and the head of the embryo grows
fastest in the early gestationalweeks,wehypothesized that
changes inmaternal plasmaLCPUFA concentration prior
to 13 weeks’ gestation are vitally important. Unfortu-
nately the direct assessment ofmaternal fatty acid changes
from prepregnancy to the first weeks of gestation is diffi-
cult in a free living population, and there are no data on
these earliest changes. Our aim therefore was to assess
plasma fatty acid changes in very early pregnancy in a
population of women undergoing natural cycle-frozen
embryo transfer as a means of achieving accurately timed
peri-conceptual sampling.
Materials and Methods
Study design, setting and participants
This prospective, observational studywas conducted atGlas-
gow Royal Infirmary and was approved by the Local Research
Ethics Committee (07/S0704/49). Women undergoing frozen
embryo transfer (FET) treatment for infertility were recruited
from the Assisted Conception Unit (ACU) between October
2007 and April 2010. Women were eligible for the study if they
had a regular menstrual cycle. Patients that had ovulation stim-
ulation or induction were excluded. No progesterone supple-
mentation or other hormonal supplements were given. All
women were recommended to take 400 g per day of folic acid
in linewithWorldHealthOrganisation guidelines.Womenwere
informed of the studywhen notifying the clinic nurse of their last
menstrual period (LMP) date with a view to booking FET treat-
ment. At day 10 after LMP (preluteinising hormone (LH) surge),
thewomen attended theACU to commence daily hormonal sam-
pling to detect the LH surge and time embryo replacement. At
this pointwomenprovidedwritten informed consent and a basal
blood sample. Embryo transferwas performedonday 3post-LH
surge. Information on patient demographics and fertility history
was collected from patient notes. Patient height and weight data
were collected at the pre-LH surge visit. Body mass index (BMI)
was calculated as weight in kg divided by height in meters
squared. Scottish Index ofMultipleDeprivation (SIMD) quintile
(10) was derived from patient postcode.
Blood sampling
Fasting blood samples were collected approximately day 10
after LMP (pre-LH surge) and on days 18, 29 and 45 post-LH
surge. Plasma was collected by low speed centrifugation and
frozen at –80°C within 2 hours. At day 18 post-LH surge the
women who were not successful in getting pregnant withdrew
from the study and therefore did not provide any blood samples
at days 29 and 45 post-LH surge.
Plasma analysis
Fatty acids were extracted from plasma and analyzed as de-
scribed in detail in the Supplemental Methods.
Statistical analyses
Data were tested for normal distribution using a Ryan Joiner
test and log or square root transformed when necessary. Values
for continuous biochemical variables are given as mean stan-
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darddeviation (SD) or number (%) for categorical variables. The
rate of change of fatty acids between time points was calculated
as the difference between the fatty acid concentration at the sec-
ond timepoint andat the first timepointdividedby thedifference
in time (days) between the two time points. The results are ex-
pressed as nmol/mL plasma per day. Incremental area under the
concentration (pre-LH surge to 45 days post-LH surge) x time
curve (iAUC) were calculated using the trapezium method with
correction for pre-LH surge parameter level (11). The results are
expressed as nmol/mL x day. Differences in concentrations of
fatty acids over time were assessed by one way ANOVA for
repeated measures, with between group comparison using post
hoc Tukey-Kramer HSD. Simultaneous difference testing be-
tween twin and singleton pregnancies across time points was
carried out using a univariate split-plot approach repeated mea-
sures analysis with post hoc ANOVA for specific time/twin sin-
gleton pregnancy differences. Associations between variables
were examined using univariate regression analysis. Prediction
of successful pregnancy outcome at day 45 post-LH surge using
18 day post-LH surge data was assessed by univariate and mul-
tivariable logistic regression. Stepwise logistic regression was
used to select variables to include in multivariable models with
the significant levels to enter and stay in model set at P  .05.
Results are reported asodds ratio (OR) [95%confidence interval
(CI)], associated P-value and theC-statistic for the area under the
curve (AUC). Odds ratios represent an increase of 1 U unless
otherwise stated for continuous variables. Statistical analyses
were performed using the JMP statistical analysis program (Ver-
sion 9.02, SAS Institute 2010, Cary, NC, USA) or SAS (Version
9.2, SAS Institute, Cary, NC, USA) and statistical significance
was set at  0.05 for all analyses.
Results
Study population
A total of 196 FET cycles were started in the study, of
which 161 were completed, from which there were 38
pregnancies: two were excluded as being a repeat attempt
at FET treatment within the study and nine were excluded
as they did not have complete data for all visits; therefore
27 pregnant women were included. From the 161 FET
cycles completed, there were 123 failed pregnancies, of
which 35 had full fatty acid data (Supplemental Figure 2).
Table 1 shows the demographic characteristics of the
27 pregnant women and 35 women not successful in get-
ting pregnant and there were no significant differences
between the two groups of women, except that use of ICSI
Table 1. Demographic characteristics of study subjects. Values are mean and standard deviation (SD) for continuous
variables or number (%) for categorical variables.
Pregnant women
(n  27)
Not successful in getting
pregnant (n  35) P
Age at FET (years) 34.7 (3.9) 33.5 (5.2) 0.33
Smokers (number [%]) 3 (11) 8 (23) 0.25
SIMD quintiles (number [%])
Affluent; Q1 & Q2 10 (37) 18 (52) 0.32
Intermediate; Q3 6 (22) 5 (14)
Deprived; Q4 & Q5 11 (41) 12 (34)
Number of previous pregnancies of  24
weeks’ gestation (number [%])
0, 1, 2 20 (74),4 (15),3 (11) 24 (71),8 (24),2 (6)* 0.57
Number of previous pregnancies of 24
weeks’ gestation (number [%])
0, 1, 2 26 (96),1 (4),0 (0) 33 (97),0 (0),1 (3)* 0.25
BMI (kg/m2) 26.2 (3.8) 26.4 (5.1) 0.88
Systolic Blood Pressure (mmHg) 116 (15) 117 (12) 0.66
Diastolic Blood Pressure (mmHg) 65 (7) 67 (9) 0.38
Reason for Treatment
Chem; Endo; Gen; Male; 0 (0);3 (11);0 (0);
15 (56);
1 (3);2 (6);1 (3); 14 (40);
0 (0)
PA; PGD; Tubal; Unexplained 1 (4);1 (4);3 (11);
3 (11)*
0 (0); 13 (37);4 (11) 0.11
Treatment
IVF; ICSI 8 (30); 19 (70) 19 (58); 14 (42)* 0.03
Number of embryos transferred
1, 2, 3 4 (15), 22 (81),1 (4) 4 (12), 30 (88),0 (0)* 0.40
Twin pregnancy according to no.
embryos transferred (number (%))
1, 2, 3 0 (0),7 (32),0 (0) N/A
BMI – Body Mass Index; Chem - Chemotherapy; Endo - Endometriosis; FET - frozen embryo transfer; Gen - Genetic; ICSI intra-cytoplasmic sperm
injection; IVF – in vitro fertilisation; Male - Male infertility; N/A – not applicable; PA - Pelvic adhesion; PGD – preimplantation genetic diagnosis; Q –
quintile; SIMD - Scottish Index of Multiple Deprivation.
* missing data points
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was significantly more prevalent in the women who be-
came pregnant.
Plasma fatty acid concentrations over the first 45
days post-LH surge
The baseline prepregnancy sample was taken at the
time of sampling to identify the LH surge prior to the
women receiving FET. The mean time of this sample was
3 days prior to the LH-surge with a standard deviation of
3 and a range of minus 12 to plus 1 day relative to the LH
surge. Plasma fatty acid concentrations over time are
shown in Table 2. Palmitic, stearic and oleic acids con-
centrations were significantly reduced by 12%–15% by
day 18 post-LH surge but their concentrations returned
back to pre-LH surge levels by day 45 post-LH surge.
Lignoceric acid concentration was significantly decreased
by 10% by day 29 and was sustained at day 45 post-LH
surge.Therewas no change inAAbut therewas a trend for
a 10% reduction in LA concentration by day 18 post-LH
surge which was maintained at days 29 and 45 post-LH
surge. -linolenic acid concentration was significantly de-
creased by 29%by day 18 post-LH surge and remained at
that concentration at day 29 post-LH surge. Dihomo--
linolenic acid, adrenic acid and omega-6 docosapen-
taenoic acid (DPA) concentrations were significantly in-
creased by 19%, 36% and 71% respectively. There were
no changes in plasma ALA and omega-3 DPA with time,
but EPA concentration decreased by 29% by day 45
post-LH surge, although the post hoc analysis did not re-
sult in significance. DHA concentration was significantly
increased by 31% by day 45 post-LH surge.
The ratio of dihomo-?-linolenic acid to LA is indicative
of -6 desaturase activity. The ratio of plasma dihomo-?-
linolenic acid toLAconcentration (mean SD)was 0.054
(0.012), 0.058 (0.011), 0.060 (0.0113) and 0.070 (0.016)
for pre-LH surge and days 18, 29 and 45 post-LH surge
respectively. The increase in -6 desaturasewas significant
by day 45 post-LH surge (P .0002). In the women who
were not successful in getting pregnant, there were no sig-
nificant changes in plasma fatty acids from pre-LH surge
to day 18 post-LH surge.
Rate of change of plasma fatty acid concentrations
and incremental AUC over the first 45 days post-
LH surge
The only plasma fatty acid with a continual increasing
rate of change in concentration (Figure 1A) and a positive
iAUC (Figure 1B) was DHA. The greatest rate of change
inDHAwas fromday18–29post-LHsurge,when the rate
of change of DHA concentration correlated significantly
with an index of -6 desaturase activity; R-squared ad-
justed  41%, P  .0002 (Supplemental Figure 3). Out-
side this time window, no such correlations were present
(pre-LH surge to day 18; R-squared adjusted –4%, P
.29: day 29 to 45 post-LH surge; R-squared adjusted 
0.1%,P .32). The other omega-3 PUFAall had stable or
decelerated rates of change in plasma concentration. ALA
had a negative iAUC (Figure 1B) which could result from
increased removal from the plasma compartment by being
converted to EPA, DPA and DHA. There was an initial
decrease in the rateof changeofplasmaAAconcentrations
from pre-LH surge to day 18 post-LH surge which then
Table 2. Plasma fatty acid concentrations from pre-LH surge to 45 days post-LH surge in pregnant women (Preg,
n  27) and women who were unsuccessful in getting pregnant (NP, n  35). Means (standard deviation) are
shown. Differences between concentrations were tested using one way Analysis of Variance for repeated measures,
across sampling from pre-LH surge (pre-pregnancy) to 18, 29 and 45 days post-LH surge and P values are given. NP
women withdrew from the study after urine pregnancy testing at day 18 post-LH surge and therefore 29 and 45
days post-LH surge samples are not available (ns) for these women. Different superscript letters indicating differences
between individual groups using post hoc Tukey-Kramer at significance level P  0.05.
Fatty Acid* (nmol/mL)
Pre-LHS
Preg
18 day
post-LHS Preg
29 day
post-LHS Preg
45 day
post-LHS Preg
P
Preg
Pre-LHS
NP
18 day
post-LHS NP
P
NP
SAFA 16:0 palmitic 2092 (346)a,b 1833 (333)a 1952 (394)a,b 2201 (453)b 0.004 1997 (437) 1998 (474) 0.92
18:0 stearic 620 (77) a 545 (87)b 552 (88)b 589 (99) a,b 0.0064 584 (89) 593 (102) 0.72
24:0 lignoceric 40 (6)a 38 (5)a,b 36 (4)b 36 (6)b 0.005 42 (7) 40 (6) 0.19
MUFA 16:1n-7 palmitoleic 202 (79) 181 (86) 183 (69) 191 (76) 0.78 200 (104) 187 (89) 0.77
18:1n-9 oleic 1770 (338) a 1512 (377) b 1623 (411) a,b 1843 (467) a 0.010 1707 (460) 1787 (470) 0.48
24:1n-9 nervonic 88 (11) 88 (12) 85 (16) 92 (18) 0.26 93 (15) 94 (20) 0.89
PUFA 18:2n-6 linoleic 2569 (384) 2297 (422) 2353 (382) 2334 (420) 0.056 2533 (353) 2495 (367) 0.60
n-6 18:3n-6 ?- linolenic 45 (18)a 32 (13)b 32 (16)b 34 (12)a,b 0.0067 42 (21) 42 (23) 0.98
20:3n-6 dihomo-?-linolenic 137 (31)a 130 (29)a 142 (36)a,b 163 (46)b 0.008 137 (33) 140 (33) 0.70
20:4n-6 arachidonic 572 (108) 546 (103) 573 (134) 627 (154) 0.16 549 (106) 535 (118) 0.53
22:4 n-6 adrenic 12 (5) a,b 11 (4) b 12 (5) a,b 15 (5) a 0.016 12 (4) 11 (5) 0.67
22:5n-6 docosapentaenoic 7 (4)a 7 (4)a 9 (4)a,b 12 (5)b 0.0005 6 (4) 7 (5) 0.60
PUFA 18:3n-3 -linolenic 68 (27) 57 (24) 57 (21) 68 (31) 0.26 66 (27) 70 (27) 0.52
n-3 20:5n-3 eicosapentaenoic 89 (47) a 69 (31) a 64 (27) a 63 (30) a 0.042 77 (43) 68 (31) 0.49
22:5n-3 docosapentaenoic 49 (15) 43 (13) 44 (17) 46 (19) 0.53 48 (15) 48 914) 0.97
22:6n-3 docosahexaenoic 145 (47)a 146 (45)a 163 (48)a,b 190 (56)b 0.003 135 (55) 131 (49) 0.75
LHS – luteinising hormone surge; MUFA - monounsaturated fatty acids; NP – not successful in becoming pregnant; Preg – successful pregnancy;
PUFA - polyunsaturated fatty acids; SAFA - saturated fatty acids. * Analysis was conducted on untransformed data except for the following: Log
transformed – 14:0, 16:0, 18:0, 16:1n-7, 18:1n-9, 24:1n-9, 18:2n-6, 20:3n-6, 20:5n-3, 22:5n-3, 22:6n-3. Square root transformed – 22:0, 24:0,
20:4n-6, 18:3n-3, 18:3n-6.
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switched to increased rates of change of plasma AA be-
tweenday18and45post-LHsurge (Figure1A).However,
overall there was no net change in AA concentration; the
iAUC was zero (Figure 1B). Other major plasma fatty ac-
ids also initially showed declining rates of increasing
plasma concentration from pre-LH surge to day 18
post-LH surge which then switched to higher rates of in-
creasing plasma concentration between day 18–45
post-LH surge (Figure 2A), however their iAUC were all
negative (Figure 2B) suggesting a loss of these fatty acids
from the plasma compartment over 45 days.Of note is the
rapid decline in plasma concentration and a correspond-
ing large negative iAUC of LA, as a decrease in LA con-
centration may allow -6 desaturase to favor DHA syn-
thesis from ALA (Supplemental Figure 1).
Plasma DHA and omega-6 DPA concentrations
over the first 45 days of gestation in twin
pregnancies
Increases in both DHA and omega-6 DPA concentra-
tions were approximately two-fold higher in twin com-
pared to singleton pregnancies (Table 3). By day 45
post-LH surge DHA plasma concentration was signifi-
cantly raised both in singleton and twin pregnancies and
the increase from pre-LH surge levels was greater in twin
(74 nmol/mL) than singleton (36 nmol/mL) pregnancies.
This two fold higher change in DHA concentration was
also observed earlier at day 29 post-LH surge: twin (161–
131  30 nmol/mL) vs singleton (163–149  14 nmol/
mL). The iAUC forDHA in twin pregnancies (1341936
nmol/mLover45days)was significantlyhigher (P0.013)
than singleton pregnancies (384 781 nmol/mL over 45
days). At day 29 post-LH surge omega-6 DPA change in
concentration from pre-LH surge was three-fold higher in
Figure 1. A Rates of change (nmol/mL plasma per day) of maternal
plasma polyunsaturated fatty acids. 20:4n-6 — —— —; 22:5n-6
. . . .f. . . .; 18:3n-3  -. -Œ. -; 22:6n-3  X . The rate of
change of fatty acids were calculated as the difference between the
fatty acid on day 18 post-LH surge and pre-LH surge and then divided
by the difference in time (days) between day 18 post–LH surge and
pre-LH surge. This was then repeated for all other time points, ie, day
29 post-LH surge and day 18 post-LH surge and then day 45 post LH-
surge and day 29 post-LH surge. The results are expressed as nmol/mL
plasma per day. B Incremental Area Under the Curve (nmol/mL
plasma x day) of maternal plasma polyunsaturated fatty acids.
Incremental areas under the time (pre-LH surge to 45 days post LH
surge) x concentration curve were calculated using the trapezium
method with correction for prepregnancy parameter level (11).
Figure 2. A Rates of change (nmol/mL plasma per day) of the
maternal major plasma fatty acids. 18:2n-6 — —— —; 18:1n-9
. . . .f. . . .; 16:0  -. -Œ. -; 18:0  X ; The rate of change
of fatty acids were calculated as the difference between the fatty acid
on day 18 post-LH surge and pre-LH surge and then divided by the
difference in time (days) between day 18 post–LH surge and pre-LH
surge. This was then repeated for all other time points, ie, day 29 post-
LH surge and day 18 post-LH surge and then day 45 post LH-surge and
day 29 post-LH surge. The results are expressed as nmol/mL plasma per
day. B Incremental Area Under the Curve (nmol/mL plasma x day) of
various maternal plasma fatty acids. Incremental areas under the time
(pre-LH surge to 45 days post- LH surge) x concentration curve were
calculated using the trapezium method with correction for
prepregnancy parameter level (11).
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twin (2.4 nmol/mL) vs singleton (0.8 nmol/mL) pregnancy
and two-fold higher at day 45 post-LH surge (7.4 nmol/
mL) vs (3.1 nmol/mL) respectively. The iAUC for omega-6
DPA tended also to be higher in twin pregnancies (9649
nmol/mL over 45 days) than in singleton pregnancies
(23  95 nmol/mL over 45 days) but this did not reach
significance (P0.060). In a multivariate mixed model,
plasma DHA levels were higher as gestation progressed
(P .0001) but did not differ between twin and singleton
pregnancy overall (P0.97). A borderline significant in-
teraction between days of gestation and twin pregnancy
(P0.06) suggests that DHA plasma concentration in-
creases are higher in twins compared to singleton preg-
nancies in response to pregnancy (R-squared adjusted
83%). In a multivariate mixed model, plasma omega-6
DPA levels were associated with day of gestation (P 
.0001) and were higher overall in twin pregnancy
(P0.04). However, the nonsignificant interaction be-
tween days of gestation and twin pregnancy (R-squared
adjusted 64%,P .10) provides less evidence that plasma
omega-6 DPA concentration is increased to a greater ex-
tent in twin pregnancy.
Linoleic acid and pregnancy outcome
There was a significant 10% reduction in plasma LA
concentration between pre-LH surge and day 18 post-LH
surge in pregnant women (P  .017) but not in women
who were not successful in getting pregnant (P  .63).
Multivariable stepwise logistic regression analysis consid-
ering all day 18 post-LH surge variables (including eryth-
rocyte fatty acid composition and insulin data not shown
here)measured inwomenwhobecamepregnant and those
womenwhodid not showed that at high insulin levels, low
LA levels and high erythrocyte saturated fatty acid levels
were associated with successful pregnancy at day 45
post-LH surge (C-statistic  0.78) (Table 4).
Discussion and conclusion
This study observed, for the first time, that uniquely
among the fatty acids measured, DHA showed a net in-
crease in concentration over the first 45 days of pregnancy
with the highest rate of increase being observed after day
18 post-LH surge. This early pressure to increase plasma
DHA concentration was further emphasized in twin preg-
nancies where the increase in concentration was double
Table 3. Comparison of singleton vs. twin pregnancy plasma 22:5n-6 and 22:6n-3 concentrations from pre-LH
surge to 45 days’ post-LH surge. Mean (standard deviation) is shown. Differences between concentrations were
tested using one way Analysis of Variance for repeated measures, across sampling gestations pre-LH surge and 18,
29 and 45 days post-LH surge and P values are given. Different superscript letters indicate differences between
individual groups using post hoc Tukey-Kramer at significance level P0.05. * analysis carried out on log transformed
data.
Fatty Acid (nmol/mL)
pre-LH surge
(pre-pregnancy)
18 days
post-LH surge
29 days
post-LH surge
45 days
post-LH surge P
Singleton (n  20)/
Twin pregnancy
(n  7)
22:5n-6 (S) 6.9 (4.9)a,b 5.9 (4.6)a 7.7 (4.1)a,b 10 (4.8)b 0.037
22:5n-6 (T) 8.6 (2.2)a 8.5 (2.3)a 11 (2.8)a 16 (4.0)b 0.0002
22:6n-3* (S) 149 (52)a 145 (48)a 163 (55)a 185 (61)a 0.093
22:6n-3* (T) 131 (28)a 151 (37)a 161 (25)a,b 205 (38)b 0.0023
LH – luteinising hormone; S, singleton pregnancy; T, twin pregnancy.
Table 4. Univariate and multivariable logistic regression models of day 18 post-LH surge variables and pregnancy
outcome at day 45 post-LH surge. Outcome was pregnant or not pregnant at day 45 post-LH surge. Covariates were
selected using stepwise logistic regression models run for day 18 post-LH surge covariates individually significant (at
P  0.05). Data shown are the univariate and multivariable odds ratio (for the given unit of change) and the 95%
confidence interval, with the associated P-value, and the C-statistic (for the Area under the Curve). The multivariable
model is a stepwise model with P-to-enter and P-to-stay each set at 0.05.
Covariate
Univariate odds ratio
(95% confidence interval) P
C-statistic
(Area Under Curve)
Multivariable odds ratio
(95% confidence interval) P
C-statistic
(Area under curve)
Day 18 post-LH surge 0.78
Log insulin (mU/liter) 2.05 (1.07, 3.92) 0.03 0.62 2.23 (1.01, 4.93) 0.048
Plasma 18:2n-6 (500 nmol/mL) 0.44 (0.24, 0.82) 0.010 0.69 0.48 (0.24, 0.99) 0.046
Erythrocyte saturated fatty acid (%) 3.37 (1.60, 7.11) 0.0014 0.70 3.12 (1.41, 6.92) 0.0050
Outcome was pregnant or not pregnant at day 45 post-LH surge. Covariates were selected using stepwise logistic regression models run for day
18 covariates individually significant (at P  0.05). Data shown are the univariate and multivariable odds ratio (for the given unit of change) and
the 95% confidence interval, with the associated P-value, and the C-statistic (for the Area under the Curve). The multivariable model is a stepwise
model with P-to-enter and P-to-stay each set at 0.05.
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that in singleton pregnancies. A 14% increase in plasma
volume at day 70 of gestation (12) suggests a change in
plasmavolumeof 6%atday18post-LHsurge and slightly
higher (7%) in twin pregnancy (13). This increase in
plasma volume cannot account for the differences inDHA
concentrationsobservedhere.Theplasma fatty acidsmea-
sured in this study reflect a complexmixture of fatty acids
bound to albumin plus those fatty acids contained within
lipoprotein particles, the transport of which is very com-
plex requiring detailed isotope tracer kinetic studieswhich
are beyond the scope of this study.
The rapid and early increase in maternal plasma DHA
concentration is consistent with our hypothesis that this
fatty acid is of critical importance early in pregnancy.
DHA, a major structural lipid in the brain, interacts with
the plasma membrane protein syntaxin-3 which is re-
quired for the membrane fusion necessary for neurite out-
growth in developing neurons (14). Previous data has
shown its importance during the latter stages of pregnancy
when the brain accrues its tissue mass (15). Our data
shows that DHA is also important during the very early
stages of pregnancy when embryological nervous tissue is
beginning to form. The timing of the increase in plasma
DHA concentration is coincident with the time at which
the very first primitive nerve cells appear and, by the time
of neural tube closure at around 28 days’ gestation, the
plasma concentration of DHA has increased significantly
by 31% and a steady rate of increasing plasma concen-
tration has been reached.
The early rise in maternal plasma DHA concentration
could be achieved either through its release from body
stores or via increased synthesis. Diet is unlikely to be
substantially changed over such a short period of time, but
cannot be discounted. Humans do not store substantial
amounts of DHA in adipose tissue, yet there is sufficient
DHA content (16) and total adipose tissue mass in preg-
nantwomen that its release fromadipose tissue could con-
tribute to the increase in plasma concentration observed
here. Another likely source is maternal de novo synthesis
in the liver. The fractional conversion rates of ALA to
DHA inmen is only 0.04% (17) withwomen being higher
at 9% (8). Our observations that 1) the initial plasma
concentrations of ALA and EPAdecrease before rebound-
ing between day 18–45; 2) the significant 10% reduction
in plasma LA in pregnant women and 3) the accelerated
increase in plasma concentration of DHA between day
18–29 post-LH surge was correlated with an index of -6
desaturase activity are all consistent with increased syn-
thesis of DHA from its precursors. This agrees with ob-
servations in pregnant rats where plasma and liver DHA
concentration as well as liver FADS2 (-6 desaturase)
mRNA expression were increased by gestation day 20
(18). The increase in liver FADS2mRNA expression was
positively correlated with plasma concentrations of preg-
nancy hormones; estradiol and progesterone (18), sug-
gesting that these hormones are responsible for up-regu-
lating DHA synthesis. The ability of women to convert
moreALAtoDHAhas alsobeenattributed to thepresence
of estrogen (8) and postmenopausal women receiving es-
trogen therapy have increased conversion (19). Low levels
of LA have previously been shown to be associated with
increasedDHA levels inmothers in the third trimester and
in their newborns (20), and this low placental transport of
maternal LA allowed -6 desaturase activity to be directed
more towards convertingALAtoDHA(20). Furthermore,
the current study shows that low levels of LA is a predictor
of successful pregnancy as indicated by positive fetal
heartbeat at day 45 post-LH surge.
The substantial decrease inmaternal plasma-linolenic
acid and the resultant increases in dihomo--linolenic acid
and omega-6 DPA indicate that the synthesis of omega-6
DPA is important, as it can be used as a substitute when
DHA supply is limited (21). In the eye, omega-6 DPA is
incorporated into rhodopsin-containing membranes
when DHA concentration is low, albeit with a resultant
reduction in visual acuity (22) and supplementation with
DHA in infants may increase visual acuity (23). In DHA
deficiency, omega-6 DPA is used in place of DHA in brain
which appears to be a survival mechanism (24–26). Our
observation of elevated omega-6 DPA, especially in twin
pregnancy, may suggest a secondary mechanism to pro-
vide an alternative LC PUFA should there be insufficient
DHA for neurological development at this critical time.
Fatty acids in oocytes are primarily saturated fatty ac-
ids, oleic acid and virtually no omega-3 PUFA (27). Once
anoocyte has been released from the ovary, the oocyte and
any resultant embryo needs to rely on its own energy
source and oocytes express the relevant lipases to release
fatty acids from triglyceride (28). Interestingly, inhibition
of oocyte fatty acid oxidation in vitro reduces blastocyst
formation and reduces the number of cells within each
blastocyst (29). Thus, saturated fatty acids are key to suc-
cessful embryo formation and implantation (30). Sperm,
on the other hand, contain predominately DHA (31),
which upon fertilization of the oocyte, delivers at least
some of the DHA needed for very early neurological de-
velopment. After implantation, the embryo must rely on
fuels transported directly to the embryo from the mother
until the fetal/maternal circulation is established at 9–11
weeks of gestation. Our data show increased plasma con-
centrations of palmitic acid and oleic acid between day 18
and 45 post-LH surge, consistent with these fatty acids
beingused tomeet the energy requirements by the embryo.
Exactly how the embryo obtains fatty acids from the ma-
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ternal circulation is yet to be elucidated, but there is evi-
dence for their simple diffusion across lipid vesicles (32).
The strengths of this study were the prospective study
design, with repeated within-individual sampling up to
day 45 post-LH surge and the comprehensive analysis of
fatty acid profilesmeasuring absolute concentrations. The
main limitation of this study was that women undergoing
in vitro fertilisation are not a “normal” pregnancy popu-
lation and it should be noted that over 40%of the women
wereundergoingassisted conceptiondue toproblemswith
female fertility. However, the women had a natural men-
strual cycle meaning there was no interference of exoge-
nous hormones used in cycle reconstruction on their met-
abolic adaptation to pregnancy. Frozen rather than fresh
embryos were transferred, but this should not impact on
the maternal metabolic response to implantation of that
embryo. Themajor advantage of the population used was
the ability to get accurately timed peri–conceptual and
early pregnancy blood samples that would be extremely
difficult to achieve from a free-living population. There
was no dietary intake data, no information on morning
sickness anddue to being unable to collect relevant tissues,
no direct measure of delta 6 desaturase activity and no
assessment of embryo/fetal tissue accrual of fatty acids.
Inferences on changes in fatty acidmetabolismweremade
using serial steady state plasma fatty acid concentrations.
While we can observe increases and decreases in plasma
concentration, it does not fully establish whether these
changes in concentration were due to changes in rates of
entry into or removal from plasma compartments as
would be described by kinetic tracer studies which are
clearly extremely difficult to perform in pregnant women.
In conclusion, increases in maternal plasma DHA con-
centration occur very early in pregnancy highlighting the
importance of DHA at this critical time when neural tube
closure takes place.
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